ES475120A1 - Imidazopyridazines and their use as therapeutic agents - Google Patents

Imidazopyridazines and their use as therapeutic agents

Info

Publication number
ES475120A1
ES475120A1 ES475120A ES475120A ES475120A1 ES 475120 A1 ES475120 A1 ES 475120A1 ES 475120 A ES475120 A ES 475120A ES 475120 A ES475120 A ES 475120A ES 475120 A1 ES475120 A1 ES 475120A1
Authority
ES
Spain
Prior art keywords
group
aryl
alkyl
aralkyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES475120A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of ES475120A1 publication Critical patent/ES475120A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms

Abstract

A process for the production of imidazo [1,5-b] pyridazine of general formula (1): *** see image 01 AND physiologically acceptable and non-toxic salts thereof, where R1 represents alkoxy, hydrogen or a group -NR4R5 where, R4 represents a hydrogen atom or an alkyl or alkenyl group and R5 represents a hydrogen atom or an amino group, Alkyl, alkenyl, aryl or aralkyl, where the aryl group or aryl radical of the aralkyl group may be optionally substituted with one or more hydroxy or alkoxy groups and where the group R5 may also represent an acyl function R6CO-, where R6 is a hydrogen atom or an adjacent nitrogen alkyl group may form a saturated 4- to 8-membered heterocyclic ring, which may contain an additional heteroatom and may contain substituents, R2 and R3, which may be the same or different, represent a straight or branched chain alkyl or alkenyl group or an aryl or aralkyl group where the aryl group or the aryl radical of the aralkyl group may be substituted with one or more hydroxy or alkoxy groups or halogen atoms and where R3 may additionally represent hydrogen atoms. (Machine-translation by Google Translate, not legally binding)
ES475120A 1977-02-09 1978-11-15 Imidazopyridazines and their use as therapeutic agents Expired ES475120A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5289/77A GB1583911A (en) 1977-02-09 1977-02-09 Imidazopyridazines and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
ES475120A1 true ES475120A1 (en) 1979-05-16

Family

ID=9793329

Family Applications (2)

Application Number Title Priority Date Filing Date
ES466795A Expired ES466795A1 (en) 1977-02-09 1978-02-08 Imidazopyridazines and their use as therapeutic agents
ES475120A Expired ES475120A1 (en) 1977-02-09 1978-11-15 Imidazopyridazines and their use as therapeutic agents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES466795A Expired ES466795A1 (en) 1977-02-09 1978-02-08 Imidazopyridazines and their use as therapeutic agents

Country Status (15)

Country Link
JP (1) JPS53101397A (en)
AU (1) AU515804B2 (en)
BE (1) BE863759A (en)
DE (1) DE2804909A1 (en)
DK (1) DK46078A (en)
ES (2) ES466795A1 (en)
FI (1) FI780350A (en)
FR (1) FR2380281A1 (en)
GB (1) GB1583911A (en)
IE (1) IE46317B1 (en)
IT (1) IT1155821B (en)
NL (1) NL7801469A (en)
NZ (1) NZ186370A (en)
SE (1) SE7801489L (en)
ZA (1) ZA78554B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473522A1 (en) * 1980-01-16 1981-07-17 Synthelabo NOVEL DIHYDRO-2,3 IMIDAZO (1,2-B) PYRIDAZINE SUBSTITUTED DERIVATIVES AND MEDICAMENTS, PARTICULARLY USEFUL AS ANTIDEPRESSANTS, CONTAINING THEM
US4391807A (en) * 1982-07-12 1983-07-05 The Dow Chemical Company 6-Substituted tetrahydroimidazo[2,1-a]phthalazines and use as bronchodilators
US4485106A (en) * 1982-07-12 1984-11-27 The Dow Chemical Company Substituted tetrahydrotetrazolo[5,1-a]phthalazines
US4391806A (en) * 1982-07-12 1983-07-05 The Dow Chemical Company Substituted tetrahydropyridazino-(1,6-A)benzimidazoles and use as bronchodilators
GB8429694D0 (en) * 1984-11-23 1985-01-03 Glaxo Group Ltd Chemical compounds
JPH07107404B2 (en) * 1991-04-22 1995-11-15 上西鉄工株式会社 Cylinder device

Also Published As

Publication number Publication date
SE7801489L (en) 1978-08-10
DE2804909A1 (en) 1978-08-10
FR2380281A1 (en) 1978-09-08
FR2380281B1 (en) 1982-03-12
IT1155821B (en) 1987-01-28
IT7847968A0 (en) 1978-02-08
ZA78554B (en) 1978-12-27
IE780186L (en) 1978-08-19
FI780350A (en) 1978-08-10
IE46317B1 (en) 1983-05-04
JPS53101397A (en) 1978-09-04
AU515804B2 (en) 1981-04-30
BE863759A (en) 1978-08-08
NZ186370A (en) 1981-03-16
GB1583911A (en) 1981-02-04
ES466795A1 (en) 1979-01-16
DK46078A (en) 1978-08-10
AU3312278A (en) 1979-08-16
NL7801469A (en) 1978-08-11

Similar Documents

Publication Publication Date Title
ES472742A1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them.
ES450550A1 (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
ES475120A1 (en) Imidazopyridazines and their use as therapeutic agents
ES457993A1 (en) Isothiazolo-pyridines
ES467069A1 (en) Pharmacologically active compounds
ES472085A1 (en) Pyranochromone derivatives and therapeutic composition comprising same for treatment of allergic diseases
ES454823A1 (en) Derivatives of imidazo 1,2-a pyridine
ES405479A1 (en) Benzodiazepin-2-ones
ES475596A1 (en) Phenoxyalkanolamine derivatives
ES450247A1 (en) Basic alcohols
ES501137A0 (en) A TIAZOL DERIVATIVE PREPARATION PROCEDURE
SE7607021L (en) ALKINE DERIVATIVES AND PROCEDURES FOR THE PREPARATION THEREOF
ES451451A1 (en) Carbamoylacetamide derivatives
SE7910387L (en) 7ALFA METOXICE PHALOSPORINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
ES483303A1 (en) Benzodiazepin derivative
ES469883A1 (en) 4-hydroxythiazolidine-2-thione derivatives
ES438056A3 (en) Procedure for the preparation of new derivatives of carboxilic acids ciclicos. (Machine-translation by Google Translate, not legally binding)
ES469955A1 (en) A procedure for the preparation of 2-nafthylamine derivatives (Machine-translation by Google Translate, not legally binding)
ES451741A2 (en) Naphthyridine derivatives
ES468330A1 (en) Normolipidemiant compositions
ES458021A1 (en) Prostenoic acid derivatives
ES483301A1 (en) A procedure for the preparation of benzodiacepine derivatives. (Machine-translation by Google Translate, not legally binding)
ES464875A1 (en) Tetracyclic compounds
ES461191A1 (en) New nn**11piperidinyl*alkyl* aryl carboxysamide derivative
ES457551A1 (en) Procedure for preparation of amino-alcoxialcanos. (Machine-translation by Google Translate, not legally binding)